Iran, Europeans to hold nuclear talks on Friday, diplomatic sources say
The talks among senior diplomats come as both sides seek to position themselves ahead of an expected fifth round of U.S.-Iranian negotiations in the coming days.
Earlier talks planned on May 2 were postponed with Britain, France and Germany, known as the E3, initially hesitant over concerns such talks could create a parallel track and hijack the negotiations pursued by the Trump administration that Washington says aim to prevent Iran from developing nuclear weapons.
But diplomats said they opted to go ahead because it was ultimately in their interest to maintain dialogue with Iran and reaffirm how they envisaged the parameters of a new nuclear deal.
Iran is also keen to hold the talks to keep its options open and assess where the European powers stand regarding the reimposition of U.N. sanctions, something Iran's foreign minister warned them on Monday against doing.
Relations between the E3 and Iran have worsened over the last year despite sporadic meetings, against a backdrop of new sanctions imposed on Tehran over its ballistic missile programme, its detention of foreign citizens and support for Russia in its war against Ukraine.
Under terms of a U.N. resolution ratifying a 2015 nuclear pact, the three European powers could reimpose United Nations sanctions against Tehran before October 18, known in diplomatic circles as the "snapback mechanism."
The European powers are not part of current negotiations between Iran and the United States, the fourth round of which ended in Oman on Sunday.
But the three powers have sought to coordinate closely with Washington with a view to whether and when they should use the snapback mechanism to raise pressure on Iran over its nuclear programme.
According to diplomats and a document seen by Reuters, the E3 countries may trigger a snapback by August if no substantial deal can be reached by then.
The next round of talks between Iran and the U.S. to resolve disputes over Tehran's nuclear programme will be held in the coming days after both sides have consulted with their respective capitals, according to Oman, which mediates the negotiations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
37 minutes ago
- The Guardian
Sales of Novo Nordisk's diabetes drugs including Ozempic slow sharply
Sales of Novo Nordisk's injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of US tariffs, prompting it to cut costs and sharpen its commercial focus. The Danish drugmaker, whose booming sales of GLP-1 diabetes and obesity drugs in recent years had turned it into Europe's most valuable company, has lost nearly $100bn (£75bn) in market value since cutting its full-year sales forecast last week, when its share price slid 30% in its worst week in more than two decades. It fell a further 3% on Wednesday. On Wednesday, Novo Nordisk said sales of medications such as Ozempic – which mimic the GLP-1 gut hormone that regulates blood sugar levels and appetite – grew by 8% in the first half of the year, down from 21% last year. Sales of obesity drugs including Wegovy increased by 56%, taking total sales 16% higher to 155bn Danish kroner (£18bn). Profit before tax climbed by 24% to 70.8bn kroner. The company has lost market share to its US rival Eli Lilly's Mounjaro, which studies have shown to be more effective, as well as cheaper versions made by generic drugmakers. It has also been hit by 'compounding' in the US, where pharmacies make up medications from ingredients, even though the US regulator declared an end to the practice recently. Novo Nordisk's outgoing chief executive, Lars Fruergaard Jørgensen, said that the copycat market had 'equal size to our business' and that compounded versions of Wegovy were sold at a 'much lower price point'. Its finance chief, Karsten Munk Knudsen, said the company was pursuing various strategies, including lawsuits against compounding pharmacies and expanding its US direct-to-consumer platform, NovoCare, launched in March. The company might also pursue 'cash sales' directly to patients elsewhere. Jørgensen said Novo Nordisk was taking measures to 'sharpen our commercial execution further, and ensure efficiencies in our cost base while continuing to invest in future growth'. He said it would probably not be able to avoid layoffs, but that no decision had been made. He said it would be up to Maziar Mike Doustdar, who takes over as CEO on Thursday, to make such a decision. The company is now expecting sales growth of between 8% and 14% at constant exchange rates in 2025, down sharply from its previous estimate of 13% to 21%. Novo Nordisk also disclosed that it had ditched several weight-loss drugs in development, including one that has just completed an intermediate (phase II) clinical study, 'due to portfolio considerations'. The company faces a class action lawsuit in the US from investors, who claim that it misled them with optimistic growth forecasts in the lucrative weight loss market. The UBS analyst Matthew Weston said: 'We expect GLP-1 compounders to remain in the US, which limits cash-pay uptake and leaves an uncertain outlook for US Wegovy. Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion 'President Trump's proposal to reimburse GLP-1 obesity in Medicare could add significant volume uplift, but most-favoured-nation demands to offer US cash sales at European prices could significantly reduce value.' Derren Nathan, the head of equity research at Hargreaves Lansdown, said: 'Tariffs and drug pricing policy are another threat Mike Doustdar will need to tackle head-on if one of Denmark's greatest success stories is to regain its crown as Europe's most valuable company. 'The 15% blanket rate on EU imports is not necessarily the end of the story as Donald Trump dangles the prospect of levies of up to 250% on pharmaceutical imports under a separate section 232 investigation.'
The Independent
an hour ago
- The Independent
Afghanistan's Taliban have 'weaponized' the judicial system to oppress women, UN expert says
Afghanistan's Taliban rulers have 'weaponized' the legal and judicial system to oppress women and girls in what amounts to 'crimes against humanity,' the independent U.N. investigator on human rights in the country said. Richard Bennett said in a report to the U.N. General Assembly circulated Wednesday that after seizing power in 2021 the Taliban suspended the 2004 constitution and laws protecting the rights of women and girls. These include a landmark law that criminalized 22 forms of violence against women, including rape and child and forced marriage. The Taliban dismissed all judges under the previous U.S.-backed government, including approximately 270 women, replacing them with men who share their extreme Islamic views, lack legal training and hand down decisions based on edicts issued by the Taliban, he said. In addition, he noted that the Taliban have assumed full control over law enforcement and investigative agencies, systematically purging Afghans who worked for the previous government. Bennett, who was appointed by the Geneva-based U.N. Human Rights Council, focused on access to justice and protection for women and girls in his report. He said he held meetings, focus-group discussions and one-on-one interviews with more that 110 Afghans inside and outside the country. He did so remotely because the Taliban have refused to grant him a visa to travel to Afghanistan. Since the Taliban took control of Afghanistan, their crackdown on women and girls has been widely reported and globally denounced. Taliban leaders have barred education for women and girls beyond sixth grade, banned most employment, and prohibited women from many public spaces, including parks, gyms and hairdressers. New laws ban women's voices and bare faces outside the home. The Taliban remain isolated from the West because of their restrictions on women and girls and have only been recognized by Russia. Bennett said the Taliban did not respond to an advance copy of the report and a request for information about their efforts to ensure access to justice and protection for women and girls. The Taliban defend their approach to justice by claiming they are implementing Islamic sharia law, but Islamic scholars and others have said their interpretation is unparalleled in other Muslim-majority countries and does not adhere to Islamic teachings. They say protecting the legal rights of women is a priority. Bennett said, however, that women have virtually no rights. 'Today, there are no women judges or prosecutors and no officially registered female lawyers, leaving women and girls with fewer safe channels to report abuse or seek redress,' he wrote. 'Coupled with a lack of female officials in the police and other institutions, the result is widespread underreporting of violence and discrimination against women and girls.' Bennett said access to justice for girls 'is further undermined by the dismantling of key legal safeguards and institutions protecting the rights of children,' including juvenile courts and juvenile rehabilitation centers. The Taliban requirement that a woman must be accompanied by a male relative also creates barriers to filing complaints and attending court proceedings, he said, and disproportionately affects widows, women who are the heads of their households, the displaced and disabled. 'Women who engage with the Taliban court system — whether as victims seeking redress, to resolve family issues, to obtain official documents or as alleged offenders — face a hostile environment,' Bennett said. ' Courts often reject complaints made by women and are especially reluctant to accept cases relating to divorce, child custody and gender-based violence.' Facing these obstacles, Bennett said, women increasingly turn to traditional and informal justice mechanisms, including formal jirgas and shuras — community councils of elders — and informal mediation by religious leaders, community elders or family. But these are all male-dominated and raise 'serious concerns about the rights of women and girls,' he said. He said international forums offer the best hope for justice. He pointed to the International Criminal Court's request on Jan. 23 for arrest warrants for two senior Taliban leaders accused of crimes against humanity for persecution 'on gender grounds.' And he urged all countries to support efforts to bring Afghanistan before the International Court of Justice, the U.N.'s highest tribunal, for violating the Convention on the Elimination of All Forms of Discrimination against Women.
The Sun
an hour ago
- The Sun
Future of chain Claire's on UK high streets uncertain after US parent firm files for bankruptcy
FASHION accessories chain Claire's is facing an uncertain future on UK high streets, after its US parent firm filed for bankruptcy. It is the second time the ear-piercing favourite has declared itself bust, after previously filing for bankruptcy in 2018. 1 Its finances are now under pressure from weak consumer demand and supply chain uncertainty. The filings showed that the parent business reported liabilities of up to $10billion (£7billion) and owed between 25,000 and 50,000 creditors. Claire's operates 2,750 stores worldwide, including 280 in the UK. While British stores remain unaffected for now, the UK arm has lost £25million over the past three years and is at risk of collapsing into administration later this month. It has been working with advisers to explore a sale or restructuring. However, potential buyers, such as Hilco Capital, are understood to have walked away. Retail experts say Claire's is struggling to stay relevant. Julie Palmer, from Begbies Traynor, said: 'Claire's low-price offering is clearly not strong enough to win over its core customers — teens and young adults — as they now have access to a vast array of affordable and convenient products online through platforms like Amazon and Temu.' Claire's boss Chris Cramer said: 'We remain in active discussions with potential strategic and financial partners and are committed to completing our review of strategic alternatives.' Nostalgic 90's retailer files for bankruptcy after chain misses rent payments for June and July 'CORE BLIMEY! MINING giant Glenciore has decided to stick with its London stock listing, scrapping plans to shift to New York, in a win for the City. It has been listed on the FTSE since 2011, when it was valued at £37billion — at the time the exchange's largest float. However, the Swiss-based firm has announced plans to slash £753million in costs by 2026, including job cuts across its 150,000-strong workforce. METRO BANK ON THE UP METRO BANK has bounced back, posting a £43.1million pre-tax profit for the first half of 2025 — up from a £33.5million loss reported in the same period last year. The lender doubled new corporate and small business loans to £1billion, and cut 8 per cent from its costs by axing a third of its workforce and reducing branch hours. Boss Daniel Frumkin said: 'Our strong performance reflects the decisive actions we have taken.' Elsewhere, Sabadell shareholders have approved the £2.65billion sale of TSB to Santander.
